Latest Communications

07 July 2010
MonoSol Rx Announces FDA Approval of Zuplenz® Oral Soluble Film for Treatment of Nausea and Vomiting

15 June 2010
APR Applied Pharma Research s.a. of Switzerland launches its new corporate website and announces key strategic changes in its Business Model to better compete in the rapidly changing Healthcare industry

09 June 2010
MonoSol Rx and APR Applied Pharma Research s.a. Expand Joint Collaboration Agreement to develop and commercialize film formulations of prescription products


About Us
Corporate Strategy
Contacts

Consistent with our Mission Statement,
we focus on three areas:

We develop and license added value, innovative healthcare products and technologies on a global basis; (you can visit our

Product Portfolio Section

)

We invest into companies or early stage innovative projects and we provide a balanced mix of capital funding and development know how; (learn more about our investment philosophy and current projects in the Think Tank Section)

We provide added value consultancy R&D Services primarily in Europe and USA using a General Contractor approach (learn more about Services)

Thanks to a unique Business Model and based on a solid set of different specific competencies, we generate an innovation flow through a multidisciplinary approach.




Search results